| Dr Christopher L Maynard, MD | |
|
1031 W Madison Ave, Athens, TN 37303-3498 | |
| (423) 745-6575 | |
| Not Available |
| Full Name | Dr Christopher L Maynard |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 38 Years |
| Location | 1031 W Madison Ave, Athens, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750386819 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD20567 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Camellia Home Health | Knoxville, TN | Home health agency |
| Guardian Home Care, Llc | Chattanooga, TN | Home health agency |
| Amedisys Home Health Chattanooga | Chattanooga, TN | Home health agency |
| Starr Regional Medical Center Athens | Athens, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summit Medical Group, Pllc | 2860396330 | 485 |
News Archive
A meta-analysis of clinical trial and real-world data suggests that drotrecogin alfa may in fact reduce mortality in patients with severe sepsis.
A Second World War veteran John Boyle died of Clostridium difficile infection after being admitted to hospital for the first time at the age of 90. He was diagnosed with the infection on January 25 this year and succumbed to it two weeks later. He was one of 18 patients to die at a Scottish hospital when the outbreak of this hospital-acquired infection was reported.
BeaconEquity.com announces an investment report featuring Antigenics Inc. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
A new analysis from the JUPITER study shows that CRESTOR (rosuvastatin) 20mg significantly cut the risk of venous thromboembolism (VTE) by 43% (p=0.007) compared to placebo among men and women with low to normal cholesterol levels and elevated high-sensitivity C-reactive protein (hsCRP).
Vertex Pharmaceuticals Incorporated announced today that 15 abstracts on the company's medicines in development for hepatitis C, including its protease inhibitor, telaprevir, and polymerase inhibitor, VX-222, were accepted for presentation at the 46th Annual Meeting of the European Association for the Study of the Liver in Berlin, Germany, March 30 to April 3, 2011.
› Verified 7 days ago
| Entity Name | Summit Medical Group, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659090298 PECOS PAC ID: 2860396330 Enrollment ID: O20031125000793 |
News Archive
A meta-analysis of clinical trial and real-world data suggests that drotrecogin alfa may in fact reduce mortality in patients with severe sepsis.
A Second World War veteran John Boyle died of Clostridium difficile infection after being admitted to hospital for the first time at the age of 90. He was diagnosed with the infection on January 25 this year and succumbed to it two weeks later. He was one of 18 patients to die at a Scottish hospital when the outbreak of this hospital-acquired infection was reported.
BeaconEquity.com announces an investment report featuring Antigenics Inc. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
A new analysis from the JUPITER study shows that CRESTOR (rosuvastatin) 20mg significantly cut the risk of venous thromboembolism (VTE) by 43% (p=0.007) compared to placebo among men and women with low to normal cholesterol levels and elevated high-sensitivity C-reactive protein (hsCRP).
Vertex Pharmaceuticals Incorporated announced today that 15 abstracts on the company's medicines in development for hepatitis C, including its protease inhibitor, telaprevir, and polymerase inhibitor, VX-222, were accepted for presentation at the 46th Annual Meeting of the European Association for the Study of the Liver in Berlin, Germany, March 30 to April 3, 2011.
› Verified 7 days ago
| Entity Name | Mcminn Medical Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689875429 PECOS PAC ID: 0749304400 Enrollment ID: O20100901000601 |
News Archive
A meta-analysis of clinical trial and real-world data suggests that drotrecogin alfa may in fact reduce mortality in patients with severe sepsis.
A Second World War veteran John Boyle died of Clostridium difficile infection after being admitted to hospital for the first time at the age of 90. He was diagnosed with the infection on January 25 this year and succumbed to it two weeks later. He was one of 18 patients to die at a Scottish hospital when the outbreak of this hospital-acquired infection was reported.
BeaconEquity.com announces an investment report featuring Antigenics Inc. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
A new analysis from the JUPITER study shows that CRESTOR (rosuvastatin) 20mg significantly cut the risk of venous thromboembolism (VTE) by 43% (p=0.007) compared to placebo among men and women with low to normal cholesterol levels and elevated high-sensitivity C-reactive protein (hsCRP).
Vertex Pharmaceuticals Incorporated announced today that 15 abstracts on the company's medicines in development for hepatitis C, including its protease inhibitor, telaprevir, and polymerase inhibitor, VX-222, were accepted for presentation at the 46th Annual Meeting of the European Association for the Study of the Liver in Berlin, Germany, March 30 to April 3, 2011.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher L Maynard, MD 1031 W Madison Ave, Athens, TN 37303-3498 Ph: (423) 745-6575 | Dr Christopher L Maynard, MD 1031 W Madison Ave, Athens, TN 37303-3498 Ph: (423) 745-6575 |
News Archive
A meta-analysis of clinical trial and real-world data suggests that drotrecogin alfa may in fact reduce mortality in patients with severe sepsis.
A Second World War veteran John Boyle died of Clostridium difficile infection after being admitted to hospital for the first time at the age of 90. He was diagnosed with the infection on January 25 this year and succumbed to it two weeks later. He was one of 18 patients to die at a Scottish hospital when the outbreak of this hospital-acquired infection was reported.
BeaconEquity.com announces an investment report featuring Antigenics Inc. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
A new analysis from the JUPITER study shows that CRESTOR (rosuvastatin) 20mg significantly cut the risk of venous thromboembolism (VTE) by 43% (p=0.007) compared to placebo among men and women with low to normal cholesterol levels and elevated high-sensitivity C-reactive protein (hsCRP).
Vertex Pharmaceuticals Incorporated announced today that 15 abstracts on the company's medicines in development for hepatitis C, including its protease inhibitor, telaprevir, and polymerase inhibitor, VX-222, were accepted for presentation at the 46th Annual Meeting of the European Association for the Study of the Liver in Berlin, Germany, March 30 to April 3, 2011.
› Verified 7 days ago
Dr. Vickie A Turnbough, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 711 Cook Dr, Suite 110, Athens, TN 37303 Phone: 423-746-0122 Fax: 423-745-9456 | |
Rebekah Danielle Sherlin-chaplin, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 325 County Road 126, Athens, TN 37303 Phone: 901-692-8880 | |
Dr. Charles Richard Sharpe, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1031 W Madison Ave, Athens, TN 37303 Phone: 423-745-6575 | |
Frederick James Barry, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1031 W Madison Ave, Athens, TN 37303 Phone: 865-373-7100 Fax: 865-373-7101 | |
Dr. Jeffrey Joseph Ivins, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 711 Cook Dr, Suite 110, Athens, TN 37303 Phone: 423-746-0122 Fax: 423-745-9456 |